This new pill could make it easier for people to stick to the treatment.
Replacing daily pills with a weekly regimen could help patients stick to their dosing schedule.
A new study finds LSD — a Schedule I drug with "no medical value" — to be therapeutically beneficial.
Why all drugs should be legalized<div class="rm-shortcode" data-media_id="EzDOdu4W" data-player_id="FvQKszTI" data-rm-shortcode-id="b4fdca9626212c286ac1ca7efde9add0"> <div id="botr_EzDOdu4W_FvQKszTI_div" class="jwplayer-media" data-jwplayer-video-src="https://content.jwplatform.com/players/EzDOdu4W-FvQKszTI.js"> <img src="https://cdn.jwplayer.com/thumbs/EzDOdu4W-1920.jpg" class="jwplayer-media-preview" /> </div> <script src="https://content.jwplatform.com/players/EzDOdu4W-FvQKszTI.js"></script> </div> <p>Interestingly, psychiatrist Robert Hyde decided to conduct his normal hospital rounds after ingesting the first American dose. He grew irritated, believing to have received a bunk dose. Problem is, Hyde was normally a pleasant man. He might not have achieved a schizophrenic state (his dose was rather low), but the LSD certainly had an emotional effect. </p><p>The government jumped aboard. The CIA's covert <a href="http://www.nytimes.com/packages/pdf/national/13inmate_ProjectMKULTRA.pdf" target="_blank">Project MKUltra</a> was instituted in hopes of manipulating Russian spies to spill secrets. Officially sanctioned in 1953 (though trials began earlier), for two decades the US government secretly dosed a range of unsuspecting mental health patients, prostitutes, drug addicts, and prisoners in attempts of discovering LSD's abilities.</p>
Sam Harris: Can psychedelics help you expand your mind?<div class="rm-shortcode" data-media_id="83HrLnMe" data-player_id="FvQKszTI" data-rm-shortcode-id="2d0c1aa224a83238f11ae8976306fdac"> <div id="botr_83HrLnMe_FvQKszTI_div" class="jwplayer-media" data-jwplayer-video-src="https://content.jwplatform.com/players/83HrLnMe-FvQKszTI.js"> <img src="https://cdn.jwplayer.com/thumbs/83HrLnMe-1920.jpg" class="jwplayer-media-preview" /> </div> <script src="https://content.jwplatform.com/players/83HrLnMe-FvQKszTI.js"></script> </div> <p>Possession of LSD became illegal in 1968; the last sanctioned FDA study on its effects took place 12 years later. Being categorized as a Schedule 1 drug (no medical value), few researchers were willing to touch it. But a recent uptick in studies have found that LSD is not medically useless. It is being tested in treatment programs for alcoholics and drug abusers. Microdosing has become a <a href="http://www.rollingstone.com/culture/features/how-lsd-microdosing-became-the-hot-new-business-trip-20151120" target="_blank">certified fad</a>. And a recent study published in <em>Nature</em> found LSD might help you <a href="http://www.nature.com/tp/journal/v7/n4/full/tp201754a.html" target="_blank">regulate your emotions</a>. </p><p>Twenty healthy participants with no or minimal (one time only) experience with psychedelics ingested either 100μg LSD or a placebo. They were then shown fearful or neutral faces while undergoing brain scans. Three brain regions were focused on: the amygdala, the seat of emotional processing, along with the fusiform gyrus and medial frontal gyrus, both areas that are responsive to fearful faces. </p><p>The researchers' hypothesis proved correct: LSD reduced amygdala activity. Those who took the substance were less emotionally volatile in response to fearful faces. To test against the possibility that the psychedelic effects distorted faces, researchers <a href="http://www.nature.com/npp/journal/v41/n11/full/npp201682a.html" target="_blank">cite a similar response</a> in subjects receiving 200μg LSD to fearful faces, who experienced no alteration in the recognition of neutral, happy, or angry faces. </p><p>This leads researchers to believe that LSD might help people suffering from anxiety disorder and depression. By "reducing perception of negative emotions and social cognitive deficits," LSD could soon find widespread usage in the psychiatrist's arsenal of remedies. Of course dose and mental history are important factors, but so far the results are positive.</p><p>In 1956, psychedelic advocate Aldous Huxley wrote in his essay, <em>Heaven and Hell</em>: </p><blockquote></blockquote><p>The psychopharmacist cannot <em>add</em> to the faculties of the brain—but he can, at best, <em>eliminate</em> obstructions and blockages which impede their proper use. He cannot aggrandise us—but he can, within limits, normalise us; he cannot put additional circuits into the brain, but he can, again within limits, improve the co-ordination between existing ones, attenuate conflicts, prevent the blowing of fuses, and ensure a steady power supply. That is all the help we can ask for—but if we were able to obtain it, the benefits to mankind would be incalculable.</p><p>Huxley was prescient in many ways. While Orwell's <em>1984</em> became a bestseller this year thanks to political turmoil in America, some <a href="https://www.theguardian.com/media/2017/feb/02/amusing-ourselves-to-death-neil-postman-trump-orwell-huxley" target="_blank">have argued</a> that <em>Brave New World</em> is a better fit of our current predicament. Though brain scanners were not available during Huxley's time he appears to have understood the nuance of LSD's effects quite well. As research shows, LSD helps us better coordinate our lives by helping us deal with our emotions in a less fearful, more thoughtful manner.</p>
There is a new era of PTSD science just around the corner.
With each passing day, the world provides us with grim reminders of a growing public health crisis. Society used to brush it off as a "case of the nerves", before labeling it as "shell shock", but today we know it as post-traumatic stress disorder (PTSD).
We know there's a gut-brain connection, but just how deep does it go? Could we treat depression just by adopting a particular diet?
British doctors eliminate the disease in two infants with incurable cancer by utilizing a medical first gene-editing techniques.
A group of British doctors successfully eliminated cancer in two infants with leukemia by using genetically modified immune cells from a donor. The accomplishment opens a new age of cancer therapy treatment.